Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004907695 | SCV005575166 | uncertain significance | not specified | 2024-08-05 | criteria provided, single submitter | clinical testing | The c.2148A>C (p.L716F) alteration is located in exon 20 (coding exon 19) of the IKBKAP gene. This alteration results from a A to C substitution at nucleotide position 2148, causing the leucine (L) at amino acid position 716 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005040124 | SCV005674545 | uncertain significance | Medulloblastoma; Familial dysautonomia | 2024-05-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001278710 | SCV001465742 | uncertain significance | Familial dysautonomia | 2020-08-13 | no assertion criteria provided | clinical testing |